Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines


TÜRK TÜRK S. , Malkan U. Y. , Ghasemi M., Hocaoglu H., Mutlu D., Gunes G. , ...Daha Fazla

SAGE OPEN MEDICINE, cilt.5, 2017 (ESCI İndekslerine Giren Dergi) identifier identifier

Özet

Objective: Ankaferd hemostat is the first topical hemostatic agent about the red blood cell-fibrinogen relations tested in the clinical trials. Ankaferd hemostat consists of standardized plant extracts including Alpinia) officinarum, Glycyrrhiza glabra, Thymus vulgaris, Urtica dioica, and Vitis vinifera. The aim of this study was to determine the effect of Ankaferd hemostat on viability of melanoma cell lines.